节点文献
半导体激光治疗中心性浆液性脉络膜视网膜病变
The long term effect of semi-conductor laser in treating central serous chorioretinopathy.
【摘要】 目的探讨半导体激光对中心性浆液性脉络膜视网膜病变(CSC)的远期疗效。方法对52例(68眼)经荧光素血管造影诊断为CSC者进行半导体激光光凝渗漏点,同时对126例(142眼)不愿行激光治疗的患者随机分为两组,一组进行传统药物治疗,一组进行醋氮酰胺口服治疗,并对患者进行追踪观察3~24月。结果激光治疗组全部在2~8周内痊愈,其中视力恢复至1.0以上者46例(58眼),视力维持治疗前不变者6例(10眼)。光凝治疗后无复发病例。醋氮酰胺治疗组59例(64眼)中,有42例(46眼)在8~24周内趋于稳定,17例(18眼)视力无明显改善或下降,12眼复发形成永久性损害。传统药物治疗组67例(78眼)中,有47例(55眼)视力在9~20周视力趋于稳定。20例(23眼)视力无明显改善或下降,14眼复发形成永久性损害。结论半导体激光光凝渗漏点能明显缩短CSC的病程,改善视力。醋氮酰胺治疗与传统药物治疗组二者之间无明显差别。
【Abstract】 Objective To study the long term effect of semi-conductor laser in treating central serous chorioretinopathy.Methods 52 patients(68 eyes) which diagnosed for CSC by FFA were treated by semi-conductor laser.126 patients(142 eyes) who did not recept the laser trear were divided into two groups,one grop were treated by acetazolamide,one group were treated by traditional medicine.All patients were followed up for 3-24 months. Results The patients treated by semi-conductor laser recovered in 2-8 weeks.Vision was above 1.0 in 46 patients(58 eyes),6 patients(10 eyes) vision had no change.In acetazolamide group,42 patients(46 eyes) vision recovered during 8-24 weeks,17 patients(18 eyes) vision had not improved or decreased,12 patients recurred.The traditional medicine group,42 patients(55 eyes) vision recovered during 9-20 weeks,20 patient(23 eyes) vision decreased and 14 paients recurred. Conclusion Semi-conductor laser can shorten the course of CSC,improve the patient’s vision.There is no difference between acetazolamide and traditional medicine group.
- 【文献出处】 眼外伤职业眼病杂志.附眼科手术 ,Chinese Journal of Ocular Trauma and Occupational Eye Disease(With Ophthalmic Surgery) , 编辑部邮箱 ,2006年01期
- 【分类号】R774.1
- 【被引频次】6
- 【下载频次】44